‘Boom, lights out’: Massachusetts man shares sudden blindness journey after taking GLP-1
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"‘Boom, lights out’: Massachusetts man shares sudden blindness journey after taking GLP-1" is generating significant coverage in the Business category, with 9 articles from 9 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Boston Globe, NewsNation, ABC News - Breaking News, Latest News and Videos and Yahoo. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 43d ago.
Quick answers
Why is "‘Boom, lights out’: Massachusetts man shares sudden blindness journey after taki" trending?
Because 9 independent news sources published 9 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (9)
- Could GLP-1s be linked to a rare type of vision loss? Here’s what to know. The Boston Globe · 46d ago
- Patients sue GLP-1 makers over sudden loss of vision NewsNation · 46d ago
- What GLP-1 users should know about the potential risk of a rare type of vision loss ABC News - Breaking News, Latest News and Videos · 46d ago
- Hundreds of lawsuits filed against some GLP-1 Makers over vision loss Yahoo · 46d ago
- Patients sue GLP-1 makers over risk of blindness WSOC TV · 46d ago
- Vision loss concerns spark US lawsuits as Australian bodies issue advice on GLP-1 drugs insightnews.com.au · 46d ago
- Are GLP-1s causing blindness? What we know about rare cases USA Today · 46d ago
- Patients Sue GLP-1 Drugmakers Over Risk of Sudden Vision Loss WSJ · 46d ago
- ‘Boom, lights out’: Massachusetts man shares sudden blindness journey after taking GLP-1 Boston 25 News · 46d ago
Topics
Related trends
NEWSLETTER: GLP-1 drugs help control prediabetes better than current standard medicine
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
Novo Nordisk raises its 2026 outlook and shares jump as the rollout of the Wegovy weight-loss pill drives strong third-quarter sales.
AI Data Center Boom Set for Upheaval After US Election Rout
US voters rejected data center developments in ballot measures, threatening the artificial intelligence expansion.
Weight-loss drugs linked to these deficiencies reported by users, research reveals
Recent coverage examines nutritional deficiencies linked to weight-loss injections and highlights the importance of protein intake.
Lizard Lounge, Cambridge Common will close next year
Two long-standing Cambridge staples, the Lizard Lounge and Cambridge Common, are set to close in 2027 after three decades of operation.
Chrissy Metz flaunts 100-lb weight loss while gushing about surprise side effects of GLP-1
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.